The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship
Open accessAbstract
BACKGROUND: Organisms resistant to antimicrobials continue to emerge and spread. This study was performed to measure the medical and societal cost attributable to antimicrobial-resistant infection (ARI). METHODS: A sample of high-risk hospitalized adult patients was selected. Measurements included ARI, total cost, duration of stay, comorbidities, acute pathophysiology, Acute Physiology and Chronic Health Evaluation III score, intensive care unit stay, surgery, health care-acquired infection, and mortality. Hospital services used and outcomes were abstracted from electronic and written medical records. Medical costs were measured from the hospital perspective. A sensitivity analysis including 3 study designs was conducted. Regression was used to adjust for potential confounding in the random sample and in the sample expanded with additional patients with ARI. Propensity scores were used to select matched control subjects for each patient with ARI for a comparison of mean cost for patients with and without ARI. RESULTS: In a sample of 1391 patients, 188 (13.5%) had ARI. The medical costs attributable to ARI ranged from $18,588 to $29,069 per patient in the sensitivity analysis. Excess duration of hospital stay was 6.4-12.7 days, and attributable mortality was 6.5%. The societal costs were $10.7-$15.0 million. Using the lowest estimates from the sensitivity analysis resulted in a total cost of $13.35 million in 2008 dollars in this patient cohort. CONCLUSIONS: The attributable medical and societal costs of ARI are considerable. Data from this analysis could form the basis for a more comprehensive evaluation of the cost of resistance and the potential economic benefits of prevention programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
Pronovost, P., Needham, D., Berenholtz, S., Sinopoli, D., Chu, H., Cosgrove, S., Sexton, B., Hyzy, R., Welsh, R., Roth, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061115 · Cited by 4,387
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726 · cited 1×
“The emergence of antimicrobial-resistant organisms is accelerating, and novel drug development is not keeping pace [1–9].”
BackgroundThe APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
Horan, T. C., Gaynes, R. P., Martone, W. J., Jarvis, W. R., & Grace Emori, T. (1992) · American Journal of Infection Control · doi:10.1016/s0196-6553(05)80201-9 · Cited by 2,609
A critical appraisal of propensity‐score matching in the medical literature between 1996 and 2003
Austin, P. C. (2008) · Statistics in Medicine · doi:10.1002/sim.3150 · Cited by 1,249
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Goldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 753
Kurth, T., Walker, A. M., Glynn, R. J., Chan, K. A., Gaziano, J. M., Berger, K., & Robins, J. M. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj047 · Cited by 730
Cited by
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Ben, Y., Fu, C., Hu, M., Liu, L., Wong, M. H., & Zheng, C. (2019) · Environmental Research · doi:10.1016/j.envres.2018.11.040 · Cited by 1,268
Tackling antibiotic resistance
Bush, K., Courvalin, P., Dantas, G., Davies, J., Eisenstein, B., Huovinen, P., Jacoby, G. A., Kishony, R., Kreiswirth, B. N., Kutter, E., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2693 · Cited by 1,062
Self-citationAntimicrobial resistance: A global emerging threat to public health systems
Ferri, M., Ranucci, E., Romagnoli, P., & Giaccone, V. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1077192 · Cited by 1,049
Li, B., & Webster, T. J. (2018) · Journal of Orthopaedic Research · doi:10.1002/jor.23656 · Cited by 907
Stemming the Superbug Tide: Just A Few Dollars More
OECD (2018) · OECD Health Policy Studies · doi:10.1787/9789264307599-en · Cited by 748
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
Fishman, N., Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, & Pediatric Infectious Diseases Society (2012) · Infection Control & Hospital Epidemiology · doi:10.1086/665010 · Cited by 677
Hospital Epidemiology and Infection Control in Acute-Care Settings
Sydnor, E. R. M., & Perl, T. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-10 · Cited by 652
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub3 · Cited by 649
Kadri, S. S., Adjemian, J., Lai, Y. L., Spaulding, A. B., Ricotta, E., Prevots, D. R., Palmore, T. N., Rhee, C., Klompas, M., Dekker, J. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy378 · Cited by 605
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Reinhart, K., Bauer, M., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 533
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
Schuetz, P., Albrich, W., & Mueller, B. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-107 · Cited by 528
The crisis of no new antibiotics—what is the way forward?
Piddock, L. J. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70316-4 · Cited by 500
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30592-3 · Cited by 486
Seven Ways to Preserve the Miracle of Antibiotics
Bartlett, J. G., Gilbert, D. N., & Spellberg, B. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit070 · Cited by 468
Persistence of antibiotic resistance in bacterial populations
Andersson, D. I., & Hughes, D. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00289.x · Cited by 435
Antibiotic-Resistant Bacteria: A Challenge for the Food Industry
Capita, R., & Alonso-Calleja, C. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.519837 · Cited by 434
Doron, S., & Davidson, L. E. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0358 · Cited by 415
Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes
Hirsch, E. B., & Tam, V. H. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.49 · Cited by 406
Perez, K. K., Olsen, R. J., Musick, W. L., Cernoch, P. L., Davis, J. R., Land, G. A., Peterson, L. E., & Musser, J. M. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0651-oa · Cited by 388
Schuetz, P. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.318 · Cited by 386
Therapeutic strategies to combat antibiotic resistance
Brooks, B. D., & Brooks, A. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.027 · Cited by 367
Cantas, L., Shah, S. Q. A., Cavaco, L. M., Manaia, C. M., Walsh, F., Popowska, M., Garelick, H., Bürgmann, H., & Sørum, H. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00096 · Cited by 357
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action
Carlet, J., Jarlier, V., Harbarth, S., Voss, A., Goossens, H., Pittet, D., & Forum, T. P. O. T. 3. W. H.-A. I. (2012) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-1-11 · Cited by 350
Bauer, K. A., West, J. E., Balada‐Llasat, J., Pancholi, P., Stevenson, K. B., & Goff, D. A. (2010) · Clinical Infectious Diseases · doi:10.1086/656623 · Cited by 347
Nathwani, D., Raman, G., Sulham, K., Gavaghan, M., & Menon, V. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-32 · Cited by 344
Perez, K. K., Olsen, R. J., Musick, W. L., Cernoch, P. L., Davis, J. R., Peterson, L. E., & Musser, J. M. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.05.005 · Cited by 321
The WHO policy package to combat antimicrobial resistance
Leung, E., Weil, D. E., Raviglione, M., & Nakatani, H. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.088435 · Cited by 320
Epidemiology and burden of multidrug-resistant bacterial infection in a developing country
Lim, C., Takahashi, E., Hongsuwan, M., Wuthiekanun, V., Thamlikitkul, V., Hinjoy, S., Day, N. P., Peacock, S. J., & Limmathurotsakul, D. (2016) · eLife · doi:10.7554/elife.18082 · Cited by 317
Economic burden of antibiotic resistance: how much do we really know?
Gandra, S., Barter, D. M., & Laxminarayan, R. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12798 · Cited by 281
Schuetz, P., Briel, M., Christ-Crain, M., Stolz, D., Bouadma, L., Wolff, M., Luyt, C.-E., Chastre, J., Tubach, F., Kristoffersen, K. B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis464 · Cited by 280
Nelson, R. E., Hatfield, K. M., Wolford, H., Samore, M. H., Scott, R. D., Reddy, S. C., Olubajo, B., Paul, P., Jernigan, J. A., & Baggs, J. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1581 · Cited by 273
Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures
Gillespie, W. J., & Walenkamp, G. H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000244.pub2 · Cited by 269
Wirz, Y., Meier, M. A., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., Schroeder, S., Nobre, V., Annane, D., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2125-7 · Cited by 265
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Müller, B., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., et al. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub2 · Cited by 264
The global need for effective antibiotics: challenges and recent advances
Högberg, L. D., Heddini, A., & Cars, O. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.08.002 · Cited by 264
Prkno, A., Wacker, C., Brunkhorst, F. M., & Schlattmann, P. (2013) · Critical Care · doi:10.1186/cc13157 · Cited by 260
Serra-Burriel, M., Keys, M., Campillo-Artero, C., Agodi, A., Barchitta, M., Gikas, A., Palos, C., & López-Casasnovas, G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227139 · Cited by 259
(BIOHAZ), E. P. O. B. H. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.2322 · Cited by 258
Behavior Change Strategies to Influence Antimicrobial Prescribing in Acute Care: A Systematic Review
Charani, E., Edwards, R., Sevdalis, N., Alexandrou, B., Sibley, E., Mullett, D., Franklin, B. D., & Holmes, A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir445 · Cited by 256
Diversity, evolution and medical applications of insect antimicrobial peptides
Mylonakis, E., Podsiadlowski, L., Muhammed, M., & Vilcinskas, A. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0290 · Cited by 254
Thorpe, K. E., Joski, P., & Johnston, K. J. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1153 · Cited by 253
He, H., Zhou, P., Shimabuku, K. K., Fang, X., Li, S., Lee, Y., & Dodd, M. C. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.8b04393 · Cited by 227
Donà, D., Barbieri, E., Daverio, M., Lundin, R., Giaquinto, C., Zaoutis, T., & Sharland, M. (2020) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0659-3 · Cited by 199
Thabit, A. K., Crandon, J. L., & Nicolau, D. P. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.993381 · Cited by 160
Metadata
- Authors
- Roberts, R. R., Hota, B., Ahmad, I., Scott II, R. D., Foster, S. D., Abbasi, F., Schabowski, S., Kampe, L. M., Ciavarella, G. G., Supino, M., Naples, J., Cordell, R., Levy, S. B., & Weinstein, R. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-10-15
- Volume
- 49
- Issue
- 8
- Pages
- 1175-1184
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2139806506
- Cited by
- 705
- References
- 42
- FWCI
- 43.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.